1985
DOI: 10.1021/jm00381a005
|View full text |Cite
|
Sign up to set email alerts
|

Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of .omega.-pyridylalkenoic acids

Abstract: A novel series of omega-pyridylalkenoic acids has been prepared by applying the Wittig reaction. Modifications were made in the omega-aryl moiety, the alkylene chain length, the alpha-methylene group adjacent to the carbonyl group, and the carboxyl group of the molecule. The compounds were tested as inhibitors of thromboxane synthetase in an in vitro assay and in ex vivo experiments with the rat. Most members of this new class of thromboxane synthetase inhibitors (TXSI) showed good activity in both assay syste… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
64
1

Year Published

1986
1986
2010
2010

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 109 publications
(67 citation statements)
references
References 0 publications
2
64
1
Order By: Relevance
“…Licofelone, bovine insulin, and anti-6-keto PGF 1␣ antibody were generous gifts by Merckle GmbH (Ulm, Germany), Sanofi-Aventis (Frankfurt, Germany), and Dr. T. Dingermann (University of Frankfurt, Frankfurt, Germany), respectively. The thromboxane synthase inhibitor CV4151 was synthesized according to Kato et al (1985). Other materials and their sources are as follows: DMEM/high-glucose (4.5 g/l) medium, penicillin, streptomycin, trypsin/EDTA solution (PAA Laboratories GmbH, Coelbe, Germany); PGH 2 (Larodan, Malmö, Sweden); 11␤-PGE 2 , PGB 1 , MK-886, 6-keto PGF 1␣ , human recombinant COX-2, ovine-isolated COX-1 (Cayman Chemical, Ann Arbor, MI); [5,6,8,9,11,12,14,15-3 H]arachidonic acid ([ 3 H]arachidonic acid) (BioTrend Chemicals GmbH, Cologne, Germany); and Ultima Gold XR (PerkinElmer Life and Analytical Sciences, Boston, MA).…”
Section: Methodsmentioning
confidence: 99%
“…Licofelone, bovine insulin, and anti-6-keto PGF 1␣ antibody were generous gifts by Merckle GmbH (Ulm, Germany), Sanofi-Aventis (Frankfurt, Germany), and Dr. T. Dingermann (University of Frankfurt, Frankfurt, Germany), respectively. The thromboxane synthase inhibitor CV4151 was synthesized according to Kato et al (1985). Other materials and their sources are as follows: DMEM/high-glucose (4.5 g/l) medium, penicillin, streptomycin, trypsin/EDTA solution (PAA Laboratories GmbH, Coelbe, Germany); PGH 2 (Larodan, Malmö, Sweden); 11␤-PGE 2 , PGB 1 , MK-886, 6-keto PGF 1␣ , human recombinant COX-2, ovine-isolated COX-1 (Cayman Chemical, Ann Arbor, MI); [5,6,8,9,11,12,14,15-3 H]arachidonic acid ([ 3 H]arachidonic acid) (BioTrend Chemicals GmbH, Cologne, Germany); and Ultima Gold XR (PerkinElmer Life and Analytical Sciences, Boston, MA).…”
Section: Methodsmentioning
confidence: 99%
“…The thromboxane synthase inhibitor CV4151 [22] and anti-6-keto PGF 1α antibody were generous gifts by Dr. S. Laufer (University of Tuebingen, Germany) and Dr. T. Dingermann (University of Frankfurt, Germany), respectively. Materials used: DMEM/High Glucose (4.5 g/l) medium, penicillin, streptomycin, trypsin/EDTA solution, PAA (Coelbe, Germany); Ultima Gold TM XR, Perkin Elmer (Boston, MA).…”
Section: Reagentsmentioning
confidence: 99%
“…The alkene moiety was favorable for activity, because reduction of the ethylenic bond in 7 resulted in decreased activity (11).…”
Section: Biological Activitymentioning
confidence: 99%